Anti-β-ngf nanobody and its application
A nanobody and antibody technology, applied in the field of biomedicine or biopharmaceuticals, can solve the problems such as the inability to meet the diverse treatment needs of the majority of patients and the single form, and achieve the effect of significant pain relief/inhibition, good effect and low immunogenicity.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0066] Example 1. Generation of Anti-Human Nerve Growth Factor (β-NGF) Nanobodies
[0067] 1.1 Immunization
[0068] Alpacas were immunized with recombinant β-NGF protein (Yiqiao Shenzhou, 11050-HNAC) together with adjuvant, complete Freund's adjuvant was used for the first immunization, and incomplete Freund's adjuvant was used from the second immunization. This time, 3 alpacas were immunized for 3-5 times. After the second immunization, blood was collected to measure the titer, and the alpacas with higher serum titers were selected for neck blood collection, and lymphocytes were separated for subsequent experiments. Elisa method to detect blood titer such as Figure 1A -B shown.
[0069] 1.2 Establishment of phage library
[0070] Take cryopreserved lymphocytes, add Trizol (Thermo Scientific, 15596-026), add 1 / 5 volume of chloroform after fully lysed, mix well, place at room temperature for 20 minutes, centrifuge at 4°C for 20 minutes at 12,000 rpm, take the upper aqueous...
Embodiment 2
[0094] Example 2. Characterization of Candidate Antibodies
[0095] 2.1 Elisa detects the binding activity of candidate antibodies to β-NGF protein
[0096] The purified candidate antibodies were tested for binding activity to determine the binding sensitivity of the candidate antibodies to β-NGF protein. This test is mainly for candidate antibodies NGF-8TTT-BA22\BA81\BA85\BA91\BA94 (hereinafter referred to as BA22\BA81\BA85\BA91\BA94), NGF-2389-CA27\CA56\BA15\BA20\BA42\BA176\ BA177 (hereinafter referred to as CA27\CA56\BA15\BA20\BA42\BA176\BA177), of which 8TTT / 2389 represent the libraries established by alpaca number 8TTT and 2389 respectively, CA represents plate screening, and BA represents magnetic bead screening.
[0097] Refer to Example 1.3 for the method of Elisa to detect the binding activity of candidate antibodies to β-NGF protein. The results are shown in Figure 2. The 12 antibodies have similar binding activities.
[0098] 2.2 Candidate antibodies block the bi...
Embodiment 3
[0108] Example 3. Humanization of BA22, BA81, BA176, CA66, CA30 sequences
[0109]Comprehensive analysis of antibody sequences, blocking data, cell activity data, etc., we selected CA66, CA30, BA22, BA81, BA176 for humanization, and continued to optimize the non-germline amino acids at both ends of the antibody sequence to reduce the risk of immunogenicity.
[0110] Table 3. Humanized Amino Acid Sequences
[0111]
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com